Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NECITUMUMAB vs NEFAZODONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NECITUMUMAB vs NEFAZODONE: Safety Overview

Metric NECITUMUMAB NEFAZODONE
Total FAERS Reports 367 284
Deaths Reported 69 11
Death Rate 18.8% 3.9%
Hospitalizations 131 37
Average Patient Age 65.4 yrs 56.4 yrs
% Female Patients 20.0% 66.6%
FDA Approval Date N/A Dec 22, 1994
Manufacturer Eli Lilly and Company Teva Pharmaceuticals USA, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued